LPGO Share Price Performance
SEK 0.0092
-0.19 (-95.36%)
Price SEK 0.0092
Share Pricen/a
Lipigon Pharmaceuticals AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 4 Fair Values set on narratives written by author
LPGO Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Lipigon Pharmaceuticals AB (publ) Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -0.059
- -2,026.42%
- -2,731.13%
- 0%
About LPGO
- Founded
- 2010
- Employees
- 7
- CEO
- WebsiteView website
Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company’s product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease; a gene therapy project for the treatment of the rare disease lipodystrophy; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia. The company was incorporated in 2010 and is based in Umeå, Sweden.
